The Association Between Mental Health Conditions and Vitiligo: A Population-Based Cohort Study in the UK
There is a significant burden of anxiety and depression in adults with vitiligo. Understanding the disease burden, and how this varies in patients diagnosed with vitiligo at different ages, and those of different ethnicities, is crucial to allow healthcare professionals to seek these psychological comorbidities and to offer the necessary psychological support to people with vitiligo.
Funding: This research was sponsored by Pfizer. Project management, medical writing, and statistical support was provided by Momentum Data, UK, and was funded by Pfizer UK.
Viktoria Eleftheriadou, MD MRCP(UK) SCE(Derm) PhD; John Nesnas, MPharm PGDipCPP PGDipPTQA
Prof Thompson was the Psychological Advisor for the APPGS 2020 mental health report and an advisor on the 2013 report. He has received grants and research funding from a number of sources. Over recent years he has received grants or/and research support from the Psoriasis and Psoriatic Arthritis Association (PAPAA), Alopecia UK, and Pfizer. He has also received honorariums to provide educational talks, and has received such support from UCB Pharma and Novartis in last two years.